Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo

Peripheral nerve injury remains a clinical challenge with severe physiological and functional consequences. Despite the existence of multiple possible therapeutic approaches, until now, there is no consensus regarding the advantages of each option or the best methodology in promoting nerve regenerat...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui D. Alvites, Mariana V. Branquinho, Ana C. Sousa, Irina Amorim, Rui Magalhães, Filipa João, Diogo Almeida, Sandra Amado, Justina Prada, Isabel Pires, Federica Zen, Stefania Raimondo, Ana L. Luís, Stefano Geuna, Artur S. P. Varejão, Ana C. Maurício
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2021/6613029
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561264824418304
author Rui D. Alvites
Mariana V. Branquinho
Ana C. Sousa
Irina Amorim
Rui Magalhães
Filipa João
Diogo Almeida
Sandra Amado
Justina Prada
Isabel Pires
Federica Zen
Stefania Raimondo
Ana L. Luís
Stefano Geuna
Artur S. P. Varejão
Ana C. Maurício
author_facet Rui D. Alvites
Mariana V. Branquinho
Ana C. Sousa
Irina Amorim
Rui Magalhães
Filipa João
Diogo Almeida
Sandra Amado
Justina Prada
Isabel Pires
Federica Zen
Stefania Raimondo
Ana L. Luís
Stefano Geuna
Artur S. P. Varejão
Ana C. Maurício
author_sort Rui D. Alvites
collection DOAJ
description Peripheral nerve injury remains a clinical challenge with severe physiological and functional consequences. Despite the existence of multiple possible therapeutic approaches, until now, there is no consensus regarding the advantages of each option or the best methodology in promoting nerve regeneration. Regenerative medicine is a promise to overcome this medical limitation, and in this work, chitosan nerve guide conduits and olfactory mucosa mesenchymal stem/stromal cells were applied in different therapeutic combinations to promote regeneration in sciatic nerves after neurotmesis injury. Over 20 weeks, the intervened animals were subjected to a regular functional assessment (determination of motor performance, nociception, and sciatic indexes), and after this period, they were evaluated kinematically and the sciatic nerves and cranial tibial muscles were evaluated stereologically and histomorphometrically, respectively. The results obtained allowed confirming the beneficial effects of using these therapeutic approaches. The use of chitosan NGCs and cells resulted in better motor performance, better sciatic indexes, and lower gait dysfunction after 20 weeks. The use of only NGGs demonstrated better nociceptive recoveries. The stereological evaluation of the sciatic nerve revealed identical values in the different parameters for all therapeutic groups. In the muscle histomorphometric evaluation, the groups treated with NGCs and cells showed results close to those of the group that received traditional sutures, the one with the best final values. The therapeutic combinations studied show promising outcomes and should be the target of new future works to overcome some irregularities found in the results and establish the combination of nerve guidance conduits and olfactory mucosa mesenchymal stem/stromal cells as viable options in the treatment of peripheral nerves after injury.
format Article
id doaj-art-082fd402c4d748238da4e6f38c5cac54
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-082fd402c4d748238da4e6f38c5cac542025-02-03T01:25:26ZengWileyStem Cells International1687-966X1687-96782021-01-01202110.1155/2021/66130296613029Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In VivoRui D. Alvites0Mariana V. Branquinho1Ana C. Sousa2Irina Amorim3Rui Magalhães4Filipa João5Diogo Almeida6Sandra Amado7Justina Prada8Isabel Pires9Federica Zen10Stefania Raimondo11Ana L. Luís12Stefano Geuna13Artur S. P. Varejão14Ana C. Maurício15Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, PortugalDepartamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, PortugalDepartamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, PortugalDepartamento de Patologia e Imunologia Molecular, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, PortugalUniversidade Católica Portuguesa, Centro de Biotecnologia e Química Fina (CBQF)-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, PortugalCentro Interdisciplinar de Estudo da Performance Humana (CIPER), Faculdade de Motricidade Humana (FMH), Universidade de Lisboa (ULisboa), 1495-751 Cruz Quebrada, PortugalInstituto Politécnico de Leiria, Unidade de Investigação em Saúde da Escola Superior de Saúde de Leiria (UIS-IPL), PortugalInstituto Politécnico de Leiria, Unidade de Investigação em Saúde da Escola Superior de Saúde de Leiria (UIS-IPL), PortugalCentro de Ciência Animal e Veterinária (CECAV), Universidade de Trás-os-Montes e Alto Douro (UTAD), Quinta de Prados, 5001-801 Vila Real, PortugalCentro de Ciência Animal e Veterinária (CECAV), Universidade de Trás-os-Montes e Alto Douro (UTAD), Quinta de Prados, 5001-801 Vila Real, PortugalDepartment of Clinical and Biological Sciences, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, Regione Gonzole 10, 10043 Orbassano, ItalyDepartment of Clinical and Biological Sciences, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, Regione Gonzole 10, 10043 Orbassano, ItalyDepartamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, PortugalDepartment of Clinical and Biological Sciences, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, Regione Gonzole 10, 10043 Orbassano, ItalyCentro de Ciência Animal e Veterinária (CECAV), Universidade de Trás-os-Montes e Alto Douro (UTAD), Quinta de Prados, 5001-801 Vila Real, PortugalDepartamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, PortugalPeripheral nerve injury remains a clinical challenge with severe physiological and functional consequences. Despite the existence of multiple possible therapeutic approaches, until now, there is no consensus regarding the advantages of each option or the best methodology in promoting nerve regeneration. Regenerative medicine is a promise to overcome this medical limitation, and in this work, chitosan nerve guide conduits and olfactory mucosa mesenchymal stem/stromal cells were applied in different therapeutic combinations to promote regeneration in sciatic nerves after neurotmesis injury. Over 20 weeks, the intervened animals were subjected to a regular functional assessment (determination of motor performance, nociception, and sciatic indexes), and after this period, they were evaluated kinematically and the sciatic nerves and cranial tibial muscles were evaluated stereologically and histomorphometrically, respectively. The results obtained allowed confirming the beneficial effects of using these therapeutic approaches. The use of chitosan NGCs and cells resulted in better motor performance, better sciatic indexes, and lower gait dysfunction after 20 weeks. The use of only NGGs demonstrated better nociceptive recoveries. The stereological evaluation of the sciatic nerve revealed identical values in the different parameters for all therapeutic groups. In the muscle histomorphometric evaluation, the groups treated with NGCs and cells showed results close to those of the group that received traditional sutures, the one with the best final values. The therapeutic combinations studied show promising outcomes and should be the target of new future works to overcome some irregularities found in the results and establish the combination of nerve guidance conduits and olfactory mucosa mesenchymal stem/stromal cells as viable options in the treatment of peripheral nerves after injury.http://dx.doi.org/10.1155/2021/6613029
spellingShingle Rui D. Alvites
Mariana V. Branquinho
Ana C. Sousa
Irina Amorim
Rui Magalhães
Filipa João
Diogo Almeida
Sandra Amado
Justina Prada
Isabel Pires
Federica Zen
Stefania Raimondo
Ana L. Luís
Stefano Geuna
Artur S. P. Varejão
Ana C. Maurício
Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo
Stem Cells International
title Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo
title_full Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo
title_fullStr Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo
title_full_unstemmed Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo
title_short Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo
title_sort combined use of chitosan and olfactory mucosa mesenchymal stem stromal cells to promote peripheral nerve regeneration in vivo
url http://dx.doi.org/10.1155/2021/6613029
work_keys_str_mv AT ruidalvites combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT marianavbranquinho combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT anacsousa combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT irinaamorim combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT ruimagalhaes combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT filipajoao combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT diogoalmeida combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT sandraamado combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT justinaprada combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT isabelpires combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT federicazen combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT stefaniaraimondo combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT analluis combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT stefanogeuna combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT arturspvarejao combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo
AT anacmauricio combineduseofchitosanandolfactorymucosamesenchymalstemstromalcellstopromoteperipheralnerveregenerationinvivo